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A

xon–glial interactions are critical for the induction of myelination and the domain organization
of myelinated ﬁbers. Although molecular complexes that mediate these interactions in the nodal region
are known, their counterparts along the internode are
poorly deﬁned. We report that neurons and Schwann
cells express distinct sets of nectin-like (Necl) proteins:
axons highly express Necl-1 and -2, whereas Schwann
cells express Necl-4 and lower amounts of Necl-2. These
proteins are strikingly localized to the internode, where
Necl-1 and -2 on the axon are directly apposed by Necl-4

on the Schwann cell; all three proteins are also enriched
at Schmidt-Lanterman incisures. Binding experiments
demonstrate that the Necl proteins preferentially mediate
heterophilic rather than homophilic interactions. In particular,
Necl-1 on axons binds speciﬁcally to Necl-4 on Schwann
cells. Knockdown of Necl-4 by short hairpin RNA inhibits
Schwann cell differentiation and subsequent myelination
in cocultures. These results demonstrate a key role for
Necl-4 in initiating peripheral nervous system myelination
and implicate the Necl proteins as mediators of axo–glial
interactions along the internode.

Introduction
Myelinated axons are organized into a series of discrete domains
that are distinguishable by their molecular composition and
physiological function. These domains include the nodes of
Ranvier, which are enriched in voltage-gated sodium channels
essential for saltatory conduction, the flanking paranodal junctions, and the juxtaparanodes, which are enriched in Shaker
type K+ channels (Poliak and Peles, 2003; Salzer, 2003). Each
of these domains forms as the result of instructive contactdependent signals from myelinating glia (i.e., Schwann cells in the
peripheral nervous system [PNS] and oligodendrocytes in the
central nervous system). Adhesion molecules on the glial cell
bind to and recruit a complex of axonal adhesion molecules and
cytoskeletal proteins; the latter include ankyrin G at the node
Correspondence to Patrice Maurel: maurep01@med.nyu.edu; or James L.
Salzer: Salzer@Saturn.med.nyu.edu
Abbreviations used in this paper: dPBS, Dulbecco’s PBS; DRG, dorsal root
ganglion; FERM, 4.1, ezrin, radixin, moesin; MAG, myelin-associated glycoprotein;
MBP, myelin basic protein; Necl, nectin-like; PDZ, PSD-95, DLG, Z01; PE, phycoerythrin; PNS, peripheral nervous system; shRNA, short hairpin RNA; SynCAM,
synaptic cell adhesion molecule; TSLC1, tumor suppressor in lung cancer 1.
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and 4.1B at the paranodes and juxtaparanodes. Interactions with
these cytoskeletal proteins target and stabilize the localization
of additional proteins (i.e., sodium channels at the node and
potassium channels at the juxtaparanodes). However, together,
these domains (the node, paranodes, and juxtaparanodes) only
account for 1% of the longitudinal extent of the axon.
The remaining and by far the largest domain of the myelinated axon is the internode, the portion of the axon located
under the compact myelin sheath. Axons and myelinating glia
exhibit an intimate functional relationship in this region, as reflected in the highly regular apposition of their respective plasma
membranes, which are separated by 12–13 nm. This separation
persists after osmotic changes or in various pathologic states
(Hirano, 1983). Conversely, the periaxonal space as well as
attachment of the myelin sheath to the axon is disrupted by the
action of proteases (Yu and Bunge, 1975). These results indicate
that interactions between the glial and axonal membranes along
the internode are actively maintained by cell surface proteins.
The molecules that mediate axonal–glial interactions along
the internode have remained largely elusive. The myelin-associated
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Figure 1. Expression of Necl proteins by Schwann cells and DRG neurons.
(A) Schematic organization of the Necl protein family. The extracellular
segment contains three Ig domains of the variable (V), constant-2 (C2), and
intermediate (I) types; the cytoplasmic region contains FERM- and PDZbinding motifs as indicated. (B) Staining of cultured Schwann cells (left
column) and of DRG somas and neurites (middle and right columns) with
antibodies to Necl-1–4 is shown. Schwann cell nuclei are stained in red.
Antibodies to Necl-1, -3, and -4 recognize the ectodomain of these proteins; the Necl-2 antibody reacts with its C terminus. Necl-1 speciﬁcally
stains neurons, whereas Necl-4 speciﬁcally stains Schwann cells. Necl-2
stains Schwann cell membranes, nuclei, and neurons. Necl-1–3 accumulate
at sites of contact between the neuronal cell somas. Bars, 50 μm.

Because of their role in mediating cell adhesion and their
linkage to 4.1 proteins, including 4.1B, which has been localized
to the paranodal and juxtaparanodal domains (Ohara et al., 2000;
Poliak et al., 2001; Denisenko-Nehrbass et al., 2003), we considered the Necl proteins to be candidates for the mediation of
axo–glial interactions in one or more of the domains of myelinated fibers. We now report that the Necl proteins are localized to
the internode of myelinated fibers in the PNS, that they bind to
both axons and Schwann cells via heterophilic interactions, and
that Necl-4 is up-regulated with and essential for myelination.
These results implicate the Necl proteins as a major new set of
cell adhesion molecules that mediate and are required for the
axo–glial interactions along the internode of myelinated axons.
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glycoprotein (MAG), a member of the Ig superfamily expressed
by myelinating Schwann cells and oligodendrocytes, has been
specifically localized to this region (Trapp, 1990). MAG is
expressed in the periaxonal glial membrane at initial stages of
myelination (Martini and Schachner, 1986) and interacts with several axonal components (Hannila et al., 2007); at later stages of
myelination, it localizes to Schmidt-Lanterman incisures as well
(Trapp, 1990). However, mice deficient in MAG myelinate appropriately and exhibit only modest alterations in the periaxonal space
(Li et al., 1994; Montag et al., 1994), suggesting that other molecules are likely to mediate axo–glial adhesion along the internode.
Recently, a family of adhesion molecules termed the Nectinlike (Necl) proteins were described (Sakisaka and Takai, 2004).
Like the nectins, a family of adherens junction proteins, the Necl
proteins contain three extracellular Ig-like domains, a single transmembrane domain, and a short cytoplasmic segment (Fig. 1 A).
Necl proteins notably differ from the nectins in their cytoplasmic sequences, which are linked to the cytoskeleton via a
FERM (4.1, ezrin, radixin, moesin)-binding domain in their juxtamembrane region and contain a class II PDZ (PSD-95, DLG, Z01)binding sequence at their C terminus. The Necl proteins have
been implicated in a variety of biological activities, including
cell adhesion, regulation of cell growth and synaptic function,
and cell polarity (for review see Ogita and Takai, 2006). They
were originally identified as tumor suppressor in lung cancer 1
(TSLC1)–like proteins, as their limited expression in lung
cancer cell lines (Gomyo et al., 1999; Fukuhara et al., 2001;
Kuramochi et al., 2001) and other tumor types (Murakami, 2005)
correlates with abnormal cell proliferation. They have also been
shown to promote synapse formation and glutamate receptor
clustering, leading to an alternative designation as synaptic cell
adhesion molecules (SynCAMs; Biederer et al., 2002).
Five Necl proteins have been identified, each independently
by several groups, which accounts for the diverse nomenclature.
The Necl proteins include Necl-1/TSLL1/SynCAM3/IgSF4B
(Fukuhara et al., 2001), Necl-2/TSLC1/SynCAM1/IGSF4/
RA175/SgIGSF (Urase et al., 2001; Ito et al., 2003; Shingai
et al., 2003), Necl-3/SynCAM2, Necl-4/TSLL2/SynCAM4, and
Necl-5/Tage4 (Ikeda et al., 2004). As Necl-5 lacks the characteristic FERM- and PDZ-binding motifs of the cytoplasmic
domain, its classification as a member of the Necl family is
controversial (Dong et al., 2006). Necl-2 is the prototype and
most intensively studied member of this family. It is widely and
highly expressed, including in the developing nervous system
and various epithelial tissues (Fukuhara et al., 2001; Urase
et al., 2001; Fujita et al., 2005). Necl-2 promotes adhesion via
homophilic (Biederer et al., 2002; Masuda et al., 2002; Shingai
et al., 2003) and heterophilic interactions (Shingai et al., 2003).
Like other Necl proteins (Dong et al., 2006; Williams et al.,
2006), Necl-2 is believed to mediate adhesion as a cis-dimer.
Necl-2 has been reported to interact intracellularly with DAL1,
a truncated form of the band 4.1B protein (Yageta et al., 2002).
Other Necl proteins are highly expressed in the nervous system,
including Necl-1 (Fukuhara et al., 2001; Gruber-Olipitz et al.,
2006) and Necl-4 (Dong et al., 2006). They are inferred to mediate adhesion although their ligands, and their modes of adhesion
are less well established.
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Results
Schwann cells and neurons express
a different set of Necl proteins
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To characterize their expression in axo–glial interactions and
for use in functional studies, we isolated full-length cDNAs for
Necl-1–4 by PCR amplification using Necl sequences present
in the genomic database. An alignment of the cloned Necl protein sequences is shown in Fig. S1 A (available at http://www
.jcb.org/cgi/content/full/jcb.200705132/DC1); their schematic
organization is shown in Fig. 1 A.
To examine the pattern of Necl protein expression in
Schwann cells, neurons, and peripheral nerves, we used a series
of antibodies. These included affinity-purified polyclonal antibodies to the C termini of Necl-1 and -2; the latter were previously reported (Masuda et al., 2002; Surace et al., 2004). Analysis
demonstrated that these antibodies were of high titer but
exhibited some cross-reactivity with the other Necl proteins;
in particular, both Necl-2 antibodies cross reacted with Necl-3
(Fig. S2 B, available at http://www.jcb.org/cgi/content/full/jcb
.200705132/DC1), likely as a result of the extensive identity of
the C termini of these two proteins. To generate specific antibodies to the Necl proteins, we constructed recombinant proteins containing the ectodomain of each Necl protein fused to
the human Ig Fc domain. These Necl-Fc fusion proteins were
individually purified and injected into guinea pigs, resulting in
the generation of antisera to Necl-1, -3, and -4. Western blotting
(Fig. S2 B) and immunocytochemistry of permanently transfected CHO cell lines expressing full-length Necl proteins (Fig.
S2 C) corroborated the specificity of each of these antisera. For
Western blot analysis, detection of the Necl proteins was markedly enhanced by treating lysates with peptide N-glycosidase F
to remove N-linked oligosaccharides (Fig. S2 A); this likely reflects the extensive glycosylation of the Necl protein ectodomain
(Masuda et al., 2002; Biederer, 2006).
We first analyzed expression of the Necl proteins by
immunofluorescence of Schwann cells and dorsal root ganglion
(DRG) neurons (Fig. 1 B). Necl-1 was not expressed by Schwann
cells but was highly expressed at the membranes of DRG
neuron cell bodies and neurites. Antibodies to the C terminus
of Necl-2 stained Schwann cell membranes and nuclei and
robustly stained the membranes of neurites and DRG somas.
Necl-3 did not stain Schwann cells or neurites, although low
level Necl-3 expression was detected at the membranes of
some neuronal somas. The lack of Necl-3 expression on
Schwann cells and DRG neurites suggests that their staining
by Necl-2 antibodies reflects the bone fide expression of Necl-2
at these sites and is not the result of cross-reactivity with
Necl-3. Necl-4 was strongly expressed at the membranes of
Schwann cells, including fine filopodial-like extensions of the
Schwann cell membrane (unpublished data). No staining of
neurites or neuronal cell bodies by Necl-4 could be detected.
These results indicate that neurons and Schwann cells express quite different sets of Necl proteins: neurites strongly
express Necl-1 and -2, whereas Schwann cells principally express Necl-4 and some Necl-2. Interestingly, Necl-1–3 accumulated at sites of contact between neuronal somas in contrast

Figure 2. Necl protein expression and Necl-4 mRNA expression.
(A) Western blot analysis of Necl protein expression by cultured Schwann
cells, DRG neurons, and cocultures under nonmyelinating (−) and myelinating (+) conditions. (B) Northern blot analysis of Necl-4 mRNA expression
in various tissues. (C) Northern blot analysis of Necl-4 mRNA expression
at different stages of sciatic nerve development.

to Necl-2 and -4, which were more diffusely expressed by
Schwann cells.
Western blotting of lysates after deglycosylation confirmed
that Necl-1 is expressed by DRG neurons but not Schwann cells,
whereas Necl-4 is expressed by Schwann cells but not by DRG
neurons (Fig. 2 A). Necl-2 was expressed by Schwann cells and
at substantially higher levels by DRG neurons. Each of these
proteins (i.e., Necl-1, -2, and -4) accumulated in 21-d-old Schwann
cell/neuron cocultures, particularly under myelinating conditions.
These results strongly suggest that expression of the Necl proteins is up-regulated with myelination. We could not detect Necl-3
expression by Schwann cells and detected only faint expression
in neurons by Western blotting, which is consistent with the
immunofluorescence data. These latter results further indicate
that the band recognized by the anti–Necl-2 antibodies in Schwann
cell and neuronal lysates is indeed Necl-2.
We also examined Necl expression by PCR and Northern
blot analysis. Northerns confirmed the high level expression of
Necl-4 in sciatic nerves (Fig. 2 B); analysis of developing sciatic
nerve demonstrated the expression of Necl- 4 mRNA perinatally
that increased with myelination (Fig. 2 C). PCR analysis confirmed
that Necl-1 and Necl-4 mRNA expression was principally restricted
to DRG neurons and Schwann cells, respectively (Fig. S3 A, available at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1),
whereas Necl-2 is expressed by both cell types (Fig. S3 B). Modest
differences in the expression of six previously described Necl-2
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isoforms, which vary slightly in their ectodomain sequences
(Biederer, 2006), were also observed by PCR analysis of neuron
and Schwann cell first-strand templates (Fig. S3 B).
Necl proteins are localized at the internode
of myelinated axons

To characterize the distribution of the Necl molecules in myelinated fibers, we stained adult mouse teased sciatic nerves.
Staining demonstrated striking and robust expression of all three
Necl proteins along the internode (i.e., the region under the
compact myelin sheath extending into the juxtaparanodal region;
Fig. 3 A). Necl-1 and -2 are essentially excluded from the
paranodes (Fig. 3 A, insets), as indicated by the limited overlap
with the paranodal marker Caspr (Einheber et al., 1997). Necl-4
is also expressed along the internode and juxtaparanodes but
could be detected in some paranodes, although at reduced levels.
864
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None of the Necl proteins were detectable at the node. We were
unable to detect any specific staining for Necl-3 in the teased
sciatic nerves (unpublished data). These findings identify the
Necl proteins as novel components of the internodal and juxtaparanodal domains.
Necl-1, -2, and -4 are also expressed at high levels in the
Schmidt-Lanterman incisures of myelinating Schwann cells
(Fig. 3 A, arrowheads). Necl-4 was expressed throughout all
layers of the incisures, whereas Necl-1 and -2 were more variable and were frequently present only in the outermost incisural
layers. The expression of Necl-1 in the incisures, a Schwann
cell–specific structure, was unexpected, as Western blots demonstrated no expression of Necl-1 by Schwann cells (Fig. 2 A).
Therefore, we undertook a developmental Northern analysis of
Necl-1 in sciatic nerve (Fig. S3, C and D). This confirmed that
Necl-1 mRNA is faintly expressed in sciatic nerve but has a
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Figure 3. The Necl proteins are localized in the internode and Schmidt-Lanterman incisures. (A) Teased sciatic nerves from adult mice were stained with
antibodies to Necl-1, -2, or -4 (red) and Caspr (green), a marker of the paranodes. Antibodies to all three Necl proteins stain the internode and SchmidtLanterman incisures (arrowheads). Nodes, which are indicated by asterisks, are shown magniﬁed in the insets without Caspr staining to demonstrate that
Necl expression is largely excluded from the paranodes. (B) Teased sciatic nerves were double stained for Necl-1 (green) and -4 (red); the merged image
is shown below. Two nodes and their ﬂanking paranodes located in the center of the ﬁeld are indicated with asterisks and are unlabeled. (C) A node of
Ranvier stained for Necl-1 (green) and -4 (red). Both Necl-1 and -4 are largely excluded from the paranodes and node, which is indicated with asterisks.
(D) An internodal segment of a myelinated nerve shows two incisures (arrowheads) that are stained with antibodies to Necl-1 (green) and -4 (red). In each
case, Necl-1 expression is restricted to the outer portion of these clefts, whereas Necl-4 stains the entire cleft. (E) A segment of a myelinated nerve stained
for Necl-4 (red) and MBP (blue) is shown. The arrowhead indicates a Schmidt-Lanterman incisure. (F) Necl-4 (red) colocalizes with MAG (green) along the
glial internode and in the clefts as shown. Bars (A and B), 25 μm; (C–F) 10 μm.
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Figure 4. Heterophilic and homophilic interactions of Necl proteins. (A) A representative experiment demonstrating the binding of Necl-Fc constructs to
monolayers of Necl-1–transfected CHO cells. Staining for the HA epitope on Necl-1 (green) and of the bound Necl proteins (red) is shown. (B) Quantitation
of the results of binding of individual Necl-Fcs to each Necl-expressing CHO cell line (mean ± SEM [error bars]). The most robust binding is between Necl-1
and -4. (C) Summary of binding in the Necl family. Binding is scored as no cells (−), <25% (+), 25–50% (++), 50–75% (+++), or 75–100% (++++)
of cells with bound Necl-Fc. Bar, 50 μm.

delayed onset of expression compared with Necl-4. These
results demonstrate that all three of these Necl proteins are
expressed in the clefts, indicating that Necl-1 and -2 expression
is up-regulated in Schwann cells with myelination.
Finally, we compared the localization of Necl-1, which is
enriched on axons, to Necl-4, which is expressed by Schwann
cells. We stained sciatic nerves with a rabbit polyclonal antibody to the C terminus of Necl-1 and the guinea pig antibody to
Necl-4. These proteins exhibited essentially identical expression
patterns along the internodal domain (Fig. 3 B, yellow in the
merged image). An example of a node is shown at higher magnification in Fig. 3 C. In the incisures, these proteins were frequently but not precisely colocalized; Fig. 3 D illustrates an
example showing Necl-1 only in the outer layers in contrast to
Necl-4, which is present throughout all layers. Double staining for

myelin basic protein (MBP) confirmed that Necl-4 (Fig. 3 E, red)
is localized just internal to the compact myelin sheath (Fig. 3 E,
blue) adjacent to the axon. The distribution of Necl-4 in the
periaxonal glial membrane and incisures is similar to that described for MAG (Trapp, 1990); double staining confirms that
these proteins indeed colocalize in these domains (Fig. 3 F).
Collectively, these studies indicate that Necl-1 on the axon is
directly apposed by Necl-4 on the periaxonal Schwann cell
membrane in the internodal domain and that the Necl proteins
are new constituents of the Schmidt-Lanterman clefts.
Necl proteins preferentially mediate
heterophilic interactions

To analyze their potential function in axo–glial interactions,
we systematically examined the ability of the Necl proteins to
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Necl proteins mediate adhesion to neurons
and Schwann cells

We next characterized binding of the Necl proteins to purified
cultures of DRG neurons and Schwann cells using a similar
strategy. In general, Necl-2 and -4 bound strongly to DRG neurites, whereas Necl-1 and -2 bound robustly to Schwann cells
(Fig. 5 A). No binding of Necl-1 to neurons and minimal binding of Necl-4 to Schwann cells was observed. These findings
indicate that the Necl proteins mediate specific adhesion to neurons and Schwann cells.
To test the ability of the Necl proteins to promote direct
Schwann cell adhesion, we examined Schwann cell attachment
to Necl-Fc fusion proteins spotted onto plastic dishes at increasing concentrations; human IgG served as a control. The density
of adherent Schwann cells at each Necl protein site was then
measured. Representative images are shown in Fig. 5 B, and the
quantitation of four separate experiments is summarized in Fig. 5 C.
Schwann cells bound at high density to the substrate-adsorbed
Necl-1–Fc but not to the Necl-2– or -4–Fc proteins. These results
confirm that Necl-1 is able to promote Schwann cell attachment
and suggest that it mediates physiologically relevant binding.
Necl-4 expression is required for Schwann
cell myelination

These results highlight a potential role of the Necl proteins in
general and of Necl-4 on Schwann cells in particular in the
axo–glial interactions of PNS myelination. To characterize the
function of the Necl proteins, we focused on Necl-4, which is
the major Necl expressed by Schwann cells and is strikingly
866
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up-regulated with myelination in the cocultures (Fig. 2). For the
knockdown, we targeted two distinct sequences within the first
Ig domain of Necl-4 (Fig. S5 E, available at http://www.jcb.org/
cgi/content/full/jcb.200705132/DC1) and subcloned the corresponding sequences into the pLL3.7 vector (Lois et al., 2002).
We infected purified Schwann cells with the lentiviral short
hairpin RNA (shRNA) constructs; Schwann cells infected with
the empty pLL3.7 vector or pLL3.7 targeting a nonspecific sequence in luciferase (shLuc) served as controls. Both shRNAs
to Necl-4 resulted in an essentially complete knockdown of
Necl-4 in Schwann cells (Figs. S5 A and 6 C), whereas Necl-2
levels were unchanged, underscoring the specificity of the
knockdown. Schwann cells were then added to established neuron cultures and maintained under myelinating conditions for
an additional 10 d.
Knockdown of Necl-4 in Schwann cells resulted in a striking inhibition of myelin segment formation compared with
control (uninfected) Schwann cells, Schwann cells infected with
vector alone, or the shRNA to luciferase (Fig. 6 A). Quantitation
of the number of MBP-positive myelin segments demonstrated
that the shRNA constructs to Necl-4 significantly inhibited myelination, corresponding to 75% inhibition for shNecl-4 construct #1 (P < 0.001) and essentially complete inhibition with
the second (shNecl-4 #2) construct (P < 0.001). In a complementary and independent set of experiments, we also infected
premyelinating neuron–Schwann cell cocultures with shRNA
construct #1; myelination was then induced by the addition of
ascorbate to the culture media. shRNA knockdown again resulted
in the extensive inhibition of myelination in the cocultures
(quantitated in Fig. S5 D). In contrast, infection of neurons with
the Necl-4 shRNA construct before seeding with Schwann cells
had no effect on myelination in cocultures (unpublished data).
To corroborate the specificity of the shRNA effects on
myelination and to exclude nonspecific off-target effects (for
review see Cullen, 2006), we performed a knockdown rescue
experiment. We expressed a modified Necl-4 protein in Schwann
cells treated with shRNA (construct #1); this Necl-4 protein
contained codon substitutions that rendered it insensitive to
shRNA treatment while preserving its amino acid sequence
(Fig. S5 E). The modified Necl-4 protein was robustly expressed
in shRNA-treated Schwann cells (Fig. 6 C) and, notably, fully
rescued myelination (Fig. 6 A). These results underscore the
specificity of the shRNA knockdown and confirm the crucial
role of Necl-4 in PNS myelination. Intriguingly, overexpression
of the Necl-4 construct may enhance myelination in the cocultures based on increased numbers of myelin segments (Fig. 6 B).
These results suggest that Necl-4 may provide a positive signal
for myelination.
Schwann cells remained associated with axons despite
the knockdown of Necl-4 based on phase microscopy (unpublished data) and immunofluorescence staining (Fig. S5 F).
Schwann cell numbers were comparable in the knockdown
cultures (Hoechst stain; Fig. 6 A). Western blot analysis of the
effects of Necl-4 knockdown corroborated the inhibition of
myelin protein expression (Fig. 6 C) and also demonstrated
substantial effects on Schwann cell transcription factor expression
(Fig. 6 D). Thus, there was dramatic inhibition of Oct-6, a
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mediate homophilic or heterophilic adhesion, focusing on Necl-1,
-2, and -4, which are expressed in the PNS. Interactions mediated by Necl-3, which is not expressed at detectable levels in the
PNS, were also examined and are shown in Fig. S4 (available
at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1).
To characterize binding within the Necl protein family, we incubated Necl-Fc fusion proteins with monolayers (Fig. 4 A) or
dissociated cell suspensions of transfected CHO cells expressing
epitope-tagged Necl proteins (Fig. S4 B). Live staining with an
anti-HA antibody verified that the Necl proteins are expressed
at the surface of the transfected cells (Figs. 4 A and S4) and facilitated the isolation of high level expressing cells via FACS. Necl-Fc
protein binding was monitored with a fluorescently labeled
anti–human Fc antibody. In the case of the dissociated CHO cells,
this binding was quantitated by FACS analysis; results are summarized in Fig. 4 (B and C).
In general, the Necl proteins preferentially mediate heterophilic adhesion. The most robust binding detected was between Necl-1 and -4; substantial binding of Necl-1 to -2 was
also observed as previously reported (Shingai et al., 2003). We
also detected modest homophilic binding by Necl-2 but not by
Necl-1 or -4. No binding of Necl-Fc proteins to control CHO
cells (i.e., cells transfected with the empty pcDNA3.1 vector)
was observed, indicating that Necl-Fc binding to transfected
cells was specific. As axons express Necl-1 and Schwann cells
principally express Necl-4, these results suggest that Necl-1 on
axons binds heterophilically to Necl-4 on Schwann cells.
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Figure 5. Binding of Necl proteins to DRG neurons and Schwann cells. (A) Conditioned media from nontransfected cells (CM) or cells transfected with individual Necl-Fc constructs were incubated with cultures of DRG neurons (top) or Schwann cells (bottom). Bound Fc constructs were visualized with ﬂuoresceinated anti–human IgG. Necl-1 Fc binds to Schwann cells but not neurons; Necl-4-Fc binds to neurons but not Schwann cells. (B) Representative phase images
of Schwann cell binding to Necl-Fc proteins. Dissociated Schwann cells were incubated with plastic substrates spotted with human IgG (control) or puriﬁed
Necl-Fc constructs. (C) Quantitation of the binding of Schwann cells to Necl-Fc constructs spotted onto dishes at the different concentrations indicated (mean ±
SEM [error bars]). Schwann cells bound robustly only to the Necl-1–Fc substrate. Bars (A), 25 μm; (B) 200 μm.

transcription factor expressed by promyelinating Schwann cells
(Scherer et al., 1994), and nearly complete inhibition of the
expression of Krox-20, a transcription factor required for the
myelinating phenotype of Schwann cells (Topilko et al., 1994).
These results indicate that Necl-4 expression is required for
progression to the promyelinating stage and subsequent myelination of axons.

Necl-1 on axons mediates binding to Necl-4
on Schwann cells

Finally, we tested the effects of knockdowns of Necl-1 and -4
on the binding of Necl proteins to axons and Schwann cells.
Knockdown of Necl-4 effectively ablated the expression of
Necl-4 at the Schwann cell membrane (Fig. 7 A, a). In the absence
of Necl-4, Necl-1 no longer bound to Schwann cells (Fig. 7 A, c).
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In contrast, Necl-2 still bound to Schwann cells in the absence
of Necl-4 (Fig. 7 A, e), indicating that its binding is independent of
Necl-4. In complementary studies, we performed a knockdown
of Necl-1 on neurons by lentiviral-mediated shRNA (Fig. 7 B).
This effectively inhibited Necl-1 expression based on Western
blotting (Fig. S5 B). In the absence of Necl-1, Necl-4 binding to
neurites was substantially reduced (Fig. 7 B). Together, these
results indicate that Necl-1 on the axon and Necl-4 on the
Schwann cell are obligate binding partners.

Discussion
We have demonstrated that neurons and Schwann cells express
distinct members of the Necl protein family. We also show that the
Necl proteins preferentially mediate heterophilic interactions
868
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Figure 6. Necl-4 expression is required for Schwann
cell differentiation and myelination. (A) Representative
images of myelinating cocultures in which control
Schwann cells or Schwann cells infected with the lentiviral vector alone or lentiviruses encoding shRNA to a
nonspeciﬁc sequence (shLuc) or to Necl-4 sequences,
in one case rescued with an exogenous Necl-4 protein
(shNecl-4 #1 + rescue), were added to DRG neurons
under myelinating conditions. Myelin segments were
stained for MBP (red) and with the Hoechst nuclear
dye (blue). (B) Quantitation of the effects of Necl-4
knockdowns on Schwann cell myelination. Control
Schwann cells or Schwann cells infected with the lentiviral vector alone or viruses encoding shRNAs to luciferase
or Necl-4 with or without rescue by an shRNA-resistant
Necl-4 were seeded onto dissociated DRG neuron cultures and maintained under myelinating conditions for
10 d. The number of myelin segments that formed
were quantitated from three separate experiments
(mean ± SEM [error bars]); controls were normalized
to 100%. *, P < 0.001. (C) Knockdown of Necl-4 inhibits myelin protein expression. Lysates from control
Schwann cells and cells infected with lentiviruses encoding shRNAs to Necl-4, including cells rescued with a
modiﬁed Necl-4 protein, were blotted for Necl-4 and
the myelin proteins MAG and P0; cultures correspond
to those shown in Fig. 6 A. shRNA treatment effectively knocked down Necl-4 and myelin protein and was
restored by the overexpression of an shRNA-resistant
Necl-4. (D) Knockdown of Necl-4 inhibits the expression of myelin transcription factors. Western blot analysis demonstrates the substantial knockdown of Necl-4
and corresponding reductions of the transcription factors
Krox-20 and Oct-6. Bar, 100 μm.

(with Necl-1 on the axon binding to Necl-4 on the Schwann cell),
that these proteins delineate the internodal domain, and that
Necl-4 mediates axonal–glial interactions required for myelination.
These results have important implications for the domain organization of axons and the mechanisms that initiate Schwann cell
myelination, as considered further below.
Schwann cells and DRG neurons express
distinct sets of Necl proteins

Previous studies demonstrated that the Necl proteins are expressed in the nervous system. Necl-1 expression was found
to be largely restricted to the developing and adult nervous
system (Fig. S3, C and D; Fukami et al., 2003; Zhou et al., 2005).
Necl-2 and -4 are also highly expressed in the nervous system
(Biederer et al., 2002; Fukami et al., 2002; Fujita et al., 2005)
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but are more broadly distributed: Necl-2 is expressed by a variety
of epithelial tissues, and Necl-4 is highly expressed by the kidney,
bladder, and prostate (Fig. 2 B; Fukuhara et al., 2001; Williams
et al., 2006). The primary sites of Necl-3 expression still remain
to be elucidated.
Our results extend these studies and indicate that neurons
and Schwann cells express different sets of Necl proteins. Thus,
DRG neurons preferentially express Necl-1 and -2, whereas
Schwann cells preferentially express Necl-4 and, at lower levels,
Necl-2 (Figs. 1 and 2). PCR data also indicate that neurons
and Schwann cells preferentially express Necl-1 and Necl-4,
respectively (Fig. S3 A). We were unable to detect the expression
of Necl-3 on axons, Schwann cells, or sciatic nerve by blotting
or immunostaining, indicating that Necl-3 is unlikely to contribute to axon–Schwann cell interactions. Low levels of Necl-3
were present at sites of contact between neuronal cell bodies.
Heterophilic interactions between Necl-1
and -4 mediate axon–Schwann
cell interactions

We systematically characterized all potential interactions within
the Necl family (Figs. 4 and S4), substantially extending previous analyses. Our data demonstrate that the Necl proteins
preferentially mediate heterophilic rather than homophilic interactions. The strongest interactors among the three Necl proteins
expressed in the PNS are Necl-1 with Necl-4. Necl-1 also
strongly binds to Necl-2, consistent with the accumulation of
both of these proteins at sites of neuronal contact (Fig. 1 B).
Homophilic interactions of Necl-2 were detected (Fig. 4) as previously reported (Biederer et al., 2002; Masuda et al., 2002) but
were less robust. We were unable to detect homophilic adhesion
mediated by Necl-1 or by Necl-4; the former result contrasts
with recent studies (Kakunaga et al., 2005; Dong et al., 2006).
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Figure 7. Necl-4 on Schwann cells binds to Necl-1 on axons. (A) Schwann cells were infected with a dilution of the lentivirus encoding shRNA (construct
#1) to Necl-4. Effects of shRNA treatment on Necl-4 expression (a) and the binding of Necl-1–Fc (c) and Necl-2–Fc (e); corresponding ﬁelds shown below
(b, d, and f) are stained for GFP to identify infected cells. Examples of infected cells are outlined by dashed white lines. (B) Necl-4–Fc does not bind to axons
in the absence of Necl-1. shRNA-treated neurons were incubated with Necl-4–Fc; robust binding is seen in control but not shRNA-treated neurites. The corresponding Western blot is shown in Fig. S5 C (available at http://www.jcb.org/cgi/content/full/jcb.200705132/DC1). Bottom panels show the same
ﬁelds stained for neuroﬁlament. Bars (A), 25 μM; (B) 40 μm.

Thus, Necl-1 and -4 likely function physiologically as heterophilic adhesion molecules.
An interaction of axonal Necl-1 with Schwann cell Necl-4
is strongly supported by several lines of evidence. Necl-1 and -2
are localized along the internodal axon in a pattern that is essentially identical to that of Necl-4 on the apposed Schwann
cell membrane (Fig. 3 B). However, although axons express
both Necl-1 and -2, Schwann cells only attached to substrates
patterned by the Necl-1–Fc protein (Fig. 5). Knockdown of
Necl-4 abolished Necl-1 but not Necl-2 binding to Schwann
cells; similarly, knockdown of Necl-1 abolished the binding of
Necl-4 to axons (Fig. 7). These latter results confirm that Necl-1
on axons binds specifically to Necl-4 on Schwann cells and suggest that the low level expression of Necl-2 on Schwann cells
does not contribute appreciably to Necl-1 adhesion.
As noted, Necl-2 is also expressed at high levels along the
internode (Fig. 3 A). Although both neurons and Schwann cells
are potential sources of Necl-2 along the internode, immunostaining of cultured cells suggests that this expression is largely
neuronal (Fig. 1 B). Preliminary immuno-EM with a Necl-2 antibody further suggests that neurons are an important source of
Necl-2 expression in the internode but also confirms the high
level expression of Necl-2 in the Schmidt-Lanterman incisures
(unpublished data). As Necl-2 binds to Schwann cells in a Necl-4–
independent manner, its ligand on the Schwann cells remains
to be determined. Necl-2 may bind via weak homophilic interactions to Schwann cells, where it is also expressed at reduced
levels (Figs. 1 B and 2 A). However, clustering of the Necl-2–Fc
bound to Schwann cells recruits only limited amounts of endogenous Necl-2 (not depicted), and Necl-2 does not accumulate at sites of contact between Schwann cells (Fig. 1 B). Thus,
Necl-2 may bind to Schwann cells by a Necl-independent
mechanism. Necl-2 has several known heterophilic ligands,
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Figure 8. Summary of Necl protein interactions within domains of myelinated ﬁbers.
Schematic diagram showing the domain organization of a myelinated axon and the potential interactions between the Necl proteins in
the internode and Schmidt-Lanterman incisures.
In the internode and juxtaparanodes (JPN),
Necl-1 on the axon binds to Necl-4 on the
Schwann cell. Necl-2 is also present on the
axon; its interacting partners on the Schwann
cell are not yet known. The Necl proteins are
also heavily expressed in the Schmidt-Lanterman
incisures of mature myelinated nerves; Necl-1
and -2 are expressed primarily in the outer
portions of the clefts (indicated), whereas Necl-4
is expressed in all layers. Potential interactions
in the clefts of Necl-1 with Necl-4 and -2 and
homophilic interactions of Necl-2 are illustrated.
There is essentially no expression of the Necl
proteins in the paranodal junctions (PNJ) or at
the node. Necl proteins are shown as cis-dimers
predicted from structural data.

Necl protein complexes delineate
the internodal domain and
Schmidt-Lanterman incisures

With the identification of the Necl proteins as mediators of
axon–glial interactions in the internode, key adhesion complexes in each of the domains of myelinated axons have now
been identified. Thus, like other domains of myelinated axons
(Poliak and Peles, 2003; Salzer, 2003; Schafer and Rasband,
2006), the internode contains a specific set of glial cell adhesion
molecules that bind to cognate adhesion molecules on the axon.
In addition to their expression in the internode, the Necl proteins are also present in the juxtaparanodes, where they are likely
to supplement the axo–glial interactions mediated by TAG-1
and Caspr2 (Poliak et al., 2003; Traka et al., 2003). The Necl
proteins are largely excluded from the paranodes (Fig. 3), although Necl-4 expression does extend into some glial paranodes
at modest levels.
The Schmidt-Lanterman clefts are the other major site of
Necl expression in mature myelinated nerves (Fig. 3 A). Necl-1
and -2 are highly expressed together with Necl-4 in this
Schwann cell–specific site; their localization at this site, together
with epithelial cadherin (E-cadherin; Fannon et al., 1995) and
MAG (Fig. 3 F), presumably contributes to organization of the
870
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incisures. Binding preferences suggest interactions of Necl-1
with -4 and Necl-1 with -2 at this site (Fig. 8). The precise
nature of the interactions remains to be established, as Necl-1
and -4 do not consistently colocalize in all layers of the clefts
(Fig. 3 D). Accumulation of the Necl proteins in the clefts may
also contribute to the increased expression that occurs during
myelination, as detected by Western blotting of the cocultures
(Fig. 2 A). The presence of Necl-1 in the clefts also indicates
that it is not strictly neuron specific but rather that it is upregulated in Schwann cells with myelination; the latter finding was confirmed by Northern blots of developing sciatic
nerve (Fig. S3 D).
The presence of the Necl proteins along the internode and
in the clefts further suggests several candidate proteins with
which they may interact at these sites. The Necl proteins contain a conserved FERM-binding domain in their cytoplasmic
sequence and have been reported to interact biochemically with
the members of the 4.1 protein family, including Necl-1 with
4.1N (Zhou et al., 2005) and Necl-2/TSLC1 with a truncated
form of 4.1B (Yageta et al., 2002). In agreement, we have identified 4.1 proteins along the internode and in the clefts (unpublished data). The Necl proteins also contain a class II PDZ
domain–binding motif at their C terminus that mediates their
interactions with membrane-associated guanylate kinase family
members. Necl-1 and -2 can interact with PDZ domain proteins
CASK (Biederer et al., 2002; Kakunaga et al., 2005), PASL2
(Shingai et al., 2003), and Dlg3 (Kakunaga et al., 2005). A variety of membrane-associated guanylate kinase proteins are
known to be concentrated in the incisures (Poliak et al., 2002)
and, therefore, are candidates to interact with the C terminus of
the Necl proteins. Finally, we note that MAG is coexpressed
with Necl-4 at high levels in the glial periaxonal membrane in
the internode and in the clefts. Whether MAG interacts either in
cis (i.e., with Necl-4) or in trans (i.e., with Necl-1 or -2) is not
yet known.
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including Nectin-3 (Shingai et al., 2003) and the class I major
histocompatibility complex–restricted T cell–associated molecule, an Ig cell adhesion molecule expressed on activated T
cells (Arase et al., 2005; Boles et al., 2005). Whether either of
these ligands is expressed by Schwann cells and mediates binding to Necl-2 on axons will require additional investigation.
Collectively, our results suggest that Necl-1 and Necl-2 on the
axon bind to Schwann cells via Necl-4 and via an as yet unknown Schwann cell receptor, respectively. The expression and
putative trans-interactions of Necl proteins in the internode are
summarized in Fig. 8.
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Necl-4 is essential for myelination

Materials and methods
Isolation of cDNAs for Necl proteins
Total RNA was isolated from puriﬁed rat Schwann cells or rat DRG neurons
with the RNAqueous-4PCR kit (Ambion); mRNA from mouse brain was puriﬁed using the mRNA isolation kit (Roche). First-strand templates were prepared by RT-PCR with an oligo-dT primer (Promega). cDNAs for Necl-1–4
were ampliﬁed using primers based on rodent sequences and cloned into
the pcDNA3.1 directional TOPO cloning vector (Invitrogen).
To clone the rat Necl-1, sense (ATGGGGGCCCCTTCCGCCCT) and
antisense (CTAGATGAAATATTCCTTCTTGTCATCCCCGCC) primers were
used to PCR amplify a full-length cDNA from rat DRG neuron ﬁrst strand
(GenBank/EMBL/DDBJ accession no. DQ272743). To clone Necl-2, we
designed primers based on the mouse cDNA for TSLC1 (Fukami et al.,
2002). We ampliﬁed a full-length cDNA from adult mouse brain with sense
(ATGGCGAGTGCTGTGCTGCC) and antisense (CTAGAAGTACTCTTTCTTTTCTTCGGAGTT) primers. This mouse isoform of Necl-2 corresponds to

isoform 4 of SynCAM 1 (Biederer et al., 2002) that lacks the putative mucinlike domain of the predicted rat sequence. The mouse Necl-2 cDNA is
available from GenBank/EMBL/DDBJ (accession no. DQ279856). Necl-3
was ampliﬁed from rat Schwann cell ﬁrst strand using sense (ATGATTTGGAAACGCAG) and antisense (TTAAATGAAATACTCTTTTTTCTC) primers,
and the sequence is available from GenBank/EMBL/DDBJ (accession no.
DQ272744). A full-length Necl-4 cDNA was ampliﬁed from rat Schwann
cell ﬁrst strand using sense (ATGGGCCGGGCCCGGCGCTTCC) and antisense (AATGAAGAATTCTTCTTTCCGTTTGTGTCCATCGCCGC) primers,
and the sequence is available from GenBank/EMBL/DDBJ (accession
no. DQ272745).
Generation of permanently transfected CHO cell lines expressing
Necl proteins
CHO cells were transfected with full-length constructs for each Necl protein
and with the empty pcDNA3.1 vector using the LipofectAMINE 2000 reagent
(Invitrogen); permanently transfected cells were selected by maintenance in
G418-containing medium (α-MEM, 10% FBS, and 750 μg/ml G418). To facilitate analysis, the sequence encoding the inﬂuenza HA epitope was added
by PCR to the N terminus of each Necl protein immediately after the signal
peptide as predicted by the SignalP program. CHO cells were stained for the
HA epitope and selected by FACS (MoFlo; DakoCytomation).
Generation of Necl-Fc fusion proteins
Constructs encoding the extracellular domain of each Necl protein fused to
the hinge region of the human IgG-Fc were subcloned into the pcDNA 3.1
TOPO vector (Invitrogen) and transiently transfected into HEK 293FT cells
(Invitrogen). Transfected cells were maintained in media containing DME,
1% Ultra Low IgG FBS (Invitrogen), 1 mM nonessential amino acids (Invitrogen), and 2 mM L-glutamine. Conditioned media was collected after 3 d
and alkalinized by 1 M Hepes buffer (Invitrogen) at 10% vol, and the salt
concentration was increased by adding 10× Dulbecco’s PBS (dPBS) at
25% vol. The conditioned media was then ﬁltered, and Necl-Fc proteins
were collected batchwise with protein A–agarose beads (Roche). The beads
were washed with 6× dPBS plus 0.2% Triton X-100 (Sigma-Aldrich) followed
by 6× dPBS and 1× dPBS washes. The proteins were eluted off the beads
with 200 mM glycine buffer at pH 2.8, immediately neutralized with 1 M
Hepes, pH 8.5, at 10% vol, and dialyzed overnight against dPBS (1:500
vol/vol) using Slide-A-Lyser dialysis cassettes (Pierce Chemical Co.). Protein
concentrations were assessed with the BCA Protein Assay (Pierce Chemical
Co.). Biochemical analysis conﬁrmed that each construct encoded proteins
of the predicted size of 65 kD after deglycosylation.
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A key finding of this study is that Necl-4 has an essential role in
the initial axo–glial interactions required for myelination. Knockdown of Necl-4 (Figs. 6 and S5) efficiently blocks Schwann cell
differentiation and myelination, as indicated by the absence of
myelin proteins and myelin segments. The limited expression of
Oct-6 and Krox-20 in the knockdown cocultures indicates that
Schwann cells are arrested before progressing to the promyelinating stage. Thus, Necl-4 is critical for axonal signaling that
drives Schwann cell differentiation and myelination.
A key question is how Necl-4 mediates these effects. One
possibility is that in the absence of Necl-4, axon–Schwann cell
apposition and interactions are impaired, preventing effective
signaling from the axon. A major axonal signal for myelination
is type III neuregulin 1, which is required for Schwann cell differentiation and regulates myelin sheath thickness (Michailov
et al., 2004; Taveggia et al., 2005). Initial results demonstrate that
Necl-4–deficient Schwann cells still attach to and amplify in
association with axons (Fig. S5 F), which is in contrast to the
aberrant interactions Schwann cells display with neuregulindeficient axons (Taveggia et al., 2005). Although preliminary,
these results suggest that other adhesion molecules can promote
the attachment of Schwann cells to the axon (Wanner and Wood,
2002) and that Necl-4 may have a distinct role in promoting
Schwann cell differentiation and myelination. Of potential interest, the Necl proteins have been implicated in promoting cell
polarity (for review see Ogita and Takai, 2006), which is a critical
early event required for the initiation of Schwann cell myelination (Chan et al., 2006; Taveggia and Salzer, 2007). Whether
Necl-4 interacts with components of the polarity complex implicated in myelination (Chan et al., 2006), as suggested by its
localization at the inner glial turn and its PDZ-binding sequences,
will be of interest for future study.
In summary, these findings suggest that Necl-4 has several
key roles in axo–glial interactions: a crucial role in promoting
Schwann cell differentiation and myelination, a potentially related
role in organizing the internodal domain by binding to Necl-1 on
the axon, and an additional role with Necl-1 and -2 in organizing
the Schmidt-Lanterman incisures. Elucidating the events downstream of Necl-4 signaling and its potential role in central nervous
system myelination are likely to provide important additional insights into the axo–glial signaling of myelination.

Antibodies and immunoﬂuorescence
Guinea pig polyclonal antibodies were generated against Necl-1, -3, and
-4 by immunization with the corresponding Necl-Fc fusion protein. Antibodies
to the human Fc moiety were removed by passing antiserum over an
agarose–human IgG (Jackson ImmunoResearch Laboratories) column.
Rabbit polyclonal antibodies to Necl-2 have previously been described
(Masuda et al., 2002; Surace et al., 2004). A rabbit polyclonal antibody
was raised to the C-terminal sequence (AEGGQSGGDDKKEYFI) of Necl-1
coupled to keyhole limpet hemocyanin and injected into rabbits, and the
resulting antibodies were afﬁnity puriﬁed against the immunizing peptide
coupled to Sepharose beads. Other antibodies included mouse monoclonal antibodies to MBP (SMI-94) and neuroﬁlament (SMI-31 and SMI-32; all
obtained from Sternberger Monoclonals) and the HA epitope (HA.11; Covance). Polyclonal antibodies speciﬁc to Krox-20 and Oct-6 (provided by
D. Meijer, Erasmus University, Rotterdam, Netherlands), Caspr (gifts from
E. Peles [Weizmann Institute, Rehovot, Israel] and M. Bhat [University of
North Carolina, Chapel Hill, NC]), MAG (Pedraza et al., 1990), and neuroﬁlament (Covance) were also used. Secondary antibodies included donkey
anti–mouse (FITC, rhodamine X, Cy5, and amino-methylcoumarin conjugated), donkey anti–guinea pig (FITC and rhodamine X conjugated), donkey
anti–rabbit (FITC and rhodamine X conjugated), donkey anti–chicken (Cy5
and amino-methylcoumarin conjugated), and goat anti–human-Fc (FITC
and rhodamine X conjugated; Jackson ImmunoResearch Laboratories). For
FACS analysis, we also used phycoerythrin (PE)-conjugated donkey anti–
mouse (eBioscience).
Immunoﬂuorescent preparations were examined by epiﬂuorescence
on a confocal microscope (LSM 510; Carl Zeiss MicroImaging, Inc.). Confocal images were acquired with Neoﬂuor 40× NA 1.3 oil or Apochromat
63× NA 1.4 oil objectives (Carl Zeiss MicroImaging, Inc.) on an 8-bit
photomultiplier tube (Carl Zeiss MicroImaging, Inc.) using LSM software
(Carl Zeiss MicroImaging, Inc.). In some cases, brightness and contrast
were adjusted with Photoshop 7.0 (Adobe).
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Preparation of teased sciatic nerves
Sciatic nerves were removed from 10–12-mo-old C57BL mice, ﬁxed with
4% PFA (Electron Microscopy Sciences) for 2 h, and stored in dPBS (Invitrogen)
at 4°C until teased. Teased sciatic nerve ﬁbers were mounted on glass
slides, dried overnight at room temperature, and stored at −80°C until use
for immunoﬂuorescence staining.
Necl binding and FACS analysis
To analyze the binding of Necl proteins to Schwann cells, DRG neurons, and
CHO-Necl clones, cells were rinsed with L15 medium (Invitrogen) and incubated for 45 min at RT with conditioned media from transiently transfected
HEK 293FT cells secreting speciﬁc Necl-Fcs. Cultures were washed once
with L15 and incubated with a FITC- or rhodamine X–conjugated goat anti–
human Fc for 45 min at room temperature. After washing with dPBS, cultures
were ﬁxed with 4% PFA. Schwann cells and CHO-Necl clones were mounted
in the presence of Hoechst dye (Invitrogen) nuclear stain. DRG neurons were
further stained for neuroﬁlaments before mounting.
To further characterize homophilic versus heterophilic Necl binding,
we performed a FACS analysis with Necl-Fc constructs. CHO cells expressing Necl proteins were brieﬂy trypsinized for 1 min with 0.125%
trypsin and 0.5 mM EDTA at room temperature, collected in ice-cold HBSS
medium (Invitrogen) containing 10% FBS to terminate trypsinization, and
washed twice in HBSS medium. Cells were diluted in HBSS to a ﬁnal concentration of 750,000 cells in 200 μl and incubated with either one of
the Necl-Fc proteins or whole human IgG at a ﬁnal concentration of 200 nM;
cells were incubated on ice for 30 min. Anti-HA antibody at 1:500 was
also added to detect the CHO-Necl cells. After incubation, cells were
washed once with ice-cold HBSS and incubated with PE-conjugated donkey anti–mouse (to detect expressing cells) and FITC-conjugated anti–
human Fc (to detect Necl-Fc binding; both at 1:100) for 30 min on ice.
After two washes in ice-cold HBSS and one wash in Ca2+/Mg2+-free icecold dPBS, ﬂuorescence measurements of individual cells were performed
using FACS (FACScan; Becton Dickinson). Log ﬂuorescence was collected
for FITC (channel FL1-H) and PE (channel FL2-H) and displayed as doubleparameter (PE/FITC) graphs. For each CHO-Necl clone, the FL2-H channel was calibrated by labeling cells for the HA tag only (no FITC), whereas
the FITC channel (no PE) was calibrated by detecting Necl-Fc, giving the
strongest binding as determined initially by binding to cells in culture. Additional controls included omitting anti-HA antibodies and Necl-Fc proteins, with only PE- and FITC-conjugated secondary antibodies added.
Analysis was ﬁrst gated on single cells on the basis of forward and side
light scatter based on data acquisition from 10,000 cells. Each CHONecl clone was incubated with human IgG as a control. The FITC ﬂuorescence value below which 99% of the events were found was noted and
used as the boundary between no binding versus binding (Fig. S4 B, left
and right red boxes). Binding of Necl-Fc was determined by counting the
number of cells in the binding gate and dividing by the total number of
cells. FACS analysis was performed with the FlowJo software package
(Tree Star, Inc.).
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Cell adhesion assay
Necl-Fc proteins serially diluted in HBSS were spotted (2 μl/spot) onto
100-mm nontissue culture polystyrene dishes (Fisherbrand; Fisher Scientiﬁc)
to minimize nonspeciﬁc cell attachment to the plastic. Duplicate spots were
made for each dilution of Necl-Fc per experiment. Plates were incubated in
a 37°C tissue culture incubator for 1 h, washed twice with HBSS, blocked
with 1% BSA in HBSS for 1 h at 37°C, washed twice with HBSS, and
washed once with D media. Schwann cells were brieﬂy trypsinized, resuspended in D media at a density of 250,000 cells/ml, and 10 ml were
added to each plate. The cultures were incubated in a 10% CO2 and 37°C
tissue culture incubator for 90 min. The plates were then gently washed
with dPBS twice, and cells were ﬁxed with 4% PFA. Phase-contrast digital
images of the spots (10× ﬁelds) were captured with a microscope (Eclipse
TE2000-U; Nikon), and the number of cells per ﬁeld was determined using
ImageJ software (National Institutes of Health).
RNAi of Necl proteins
To generate shRNAs, we used the pLentiLox (pLL3.7) vector in which the U6
promoter drives shRNA expression and GFP is expressed under separate
promoter control (provided by L. Van Parijs; Rubinson et al., 2003; Dillon
et al., 2005). Two 21 nucleotide shRNAs (#1: nt 79–99, GTGCAGACAGAGAATGTGACG; #2: nt 151–171, GGGTCTATAGTCGTCATTCAG) that
targeted sequences within the ﬁrst IgG domain of Necl-4 were designed
using Easy siRNA (ProteinLounge), BLOCK-iT RNAi designer (Invitrogen),
and siRNA sequence selector (CLONTECH Laboratories, Inc.). The shRNA
stem loops for pLL3.7 vector were designed to contain a sense shRNA sequence followed by a short (9 nt) nonspeciﬁc loop sequence and an antisense shRNA sequence followed by six thymidines, which serve as a stop
signal for RNA polymerase III. The 5′-phosphorylated PAGE-puriﬁed oligonucleotides were annealed and subcloned into HpaI–XhoI sites of pLL3.7.
The lentiviral vector was transfected into 293FT cells together with packaging plasmids ∆8.9 and pCMV-VSVG (provided by J. Milbrandt, Washington
University, St. Louis, MO) using LipofectAMINE 2000 (Invitrogen). As controls,
we used the empty pLL3.7 vector or a vector encoding shRNA to a nonspeciﬁc (luciferase) sequence. Viral supernatants were collected 72 h after
transfection, centrifuged at 3,000 rpm for 15 min, aliquoted for one-time use,
and frozen at −80°C. An shRNA targeting a 21-nt sequence (nt 733–753;
GTGCAGACAGAGAATGTGACG) in the third IgG domain of Necl-1 was
designed using the same approach.
For rescue experiments, a codon-modiﬁed Necl-4 construct was generated using the QuikChange XL Site-Directed Mutagenesis kit (Stratagene).
The sequence GTGCAGACAGAGAATGTGACG (nt 79–99) was replaced
with sequence GTACAAACGGAAAACGTAACA, which did not change
the amino acid composition of Necl-4 but rendered the construct insensitive
to the Necl-4–speciﬁc shRNA #1. The modiﬁed Necl-4 was subcloned into
the pLenti6/V5 Directional Topo vector (Invitrogen), and viral production
was performed as per the pLL3.7 constructs.
Freshly plated Schwann cells (106 cells per 100-mm plate) were
incubated for 3 d with viruses at a 2/3 dilution (vol/vol) in D media (DME,
10% FBS, and 2 mM L-glutamine) supplemented with forskolin and rhNRGβ1 (EGF domain). Cells were expanded for an additional week and maintained for 3 d in D media before use. Protein knockdowns were conﬁrmed
by Western blotting and by immunohistochemistry.
Northern blot analysis
RNA was isolated from rat sciatic nerves and Schwann cells by CsCl2 gradient centrifugation (Chirgwin et al., 1979). Equal amounts (10 μg) of total
RNA were electrophoresed in 1% agarose and 2.2 M formaldehyde gels,
transferred to nylon membranes (Duralon; Stratagene) in 6× SSC, and UV
cross-linked (0.12 J). Blots were prehybridized, hybridized, and washed
using standard techniques; the ﬁnal stringency of the wash was 0.2× SSC
at 65°C for 30 min (Sambrook et al., 1989). cDNAs corresponding to
nt 1–981 of rat Necl-1 and nt 1–966 of rat Necl-4 were used as probes.
The probes were generated by PCR, isolated by agarose gel electrophoresis,
and puriﬁed with the QIAquick Gel Extraction kit (QIAGEN). 32P-labeled
cDNA probes with speciﬁc activities of 2–5 × 109 cpm/μg were prepared by
primer extension with random hexamers using the Prim-a-gene kit (Promega)
according to the manufacturer’s instructions
Software
Sequence alignments were performed with the Clustal V program (Higgins,
1994). The Necl proteins were analyzed for the presence of putative
domains using the following programs and databases: SignalP (Nielsen
et al., 1997) and TMHHM (Nielsen and Krogh, 1998), Pfam (Bateman
et al., 2004), SMART (Schultz et al., 1998), and Scansite 2.0 (Obenauer
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Neuron and Schwann cell cultures
Establishment of primary rat Schwann cell and DRG neuron cultures has
been described previously (Einheber et al., 1993). In brief, neurons were
isolated from embryonic day 16 DRGs by trypsinization and plated on a
collagen substrate (Biomedical Technologies Inc.) in standard neuronal
medium (neurobasal medium, 2% B27 supplement, 2 mM L-glutamine, 0.4%
glucose, and 50 ng/ml 2.5S NGF). Nonneuronal cells were removed by
feeding the cultures every 2 d alternately with standard neuronal medium
supplemented or not supplemented with 5-ﬂuorodeoxyuridine and uridine
(both at 10 μM) over a week. Schwann cells prepared from postnatal day
2 sciatic nerves (Brockes et al., 1979) were expanded in D media (DME,
10% FBS, and 2 mM L-glutamine) supplemented with 4 μM forskolin and
5 ng/ml of the EGF domain of rhNRG-1-β1 (over a period of 2–3 wk; R&D
Systems). Schwann cells were then maintained in D media for 3 d before
use. Myelinating Schwann cell–neuron cocultures were established by
seeding puriﬁed DRG neuron cultures with 200,000 Schwann cells in C media
(MEM, 10% FBS, 2 mM L-glutamine, 0.4% glucose, and 50 ng/ml 2.5S
NGF). After 3 d, cocultures were supplemented with 50 μg/ml ascorbic
acid to initiate basal lamina formation and myelination and were maintained
for an additional 10–21 d.
DME was obtained from BioWhittaker Bioproducts. α-MEM, MEM,
neurobasal media, B27 supplement, L-glutamine, trypsin, and G418 were
purchased from Life Technologies. Glucose, forskolin, 5-ﬂuorodeoxyuridine,
uridine, and ascorbic acid were purchased from Sigma-Aldrich. FBS was
obtained from Gemini, and NGF was purchased from Harlan Bioproducts.
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et al., 2003). Statistical analysis was performed with the Prism software
package (GraphPad).
Online supplemental material
Fig. S1 presents amino acid sequences of the Necl proteins. Fig. S2 shows
Necl expression CHO cell lines and speciﬁcity of anti-Necl antibodies.
Fig. S3 shows PCR of Necl-2 isoforms and Northern analysis of Necl-1.
Fig. S4 presents the binding of Necl-Fc fusion proteins to Necl-expressing
cells. Fig. S5 shows that the knockdown of Necl-4 inhibits myelination in
cocultures. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200705132/DC1.
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